Brokerages predict that Medley Capital Corp (NYSE:MCC) will report $22.87 million in sales for the current quarter, according to Zacks. Three analysts have made estimates for Medley Capital’s earnings, with the highest sales estimate coming in at $23.95 million and the lowest estimate coming in at $21.64 million. Medley Capital posted sales of $26.06 million during the same quarter last year, which suggests a negative year over year growth rate of 12.2%. The firm is expected to issue its next quarterly earnings report before the market opens on Tuesday, February 6th.
According to Zacks, analysts expect that Medley Capital will report full year sales of $22.87 million for the current fiscal year, with estimates ranging from $87.48 million to $96.00 million. For the next year, analysts anticipate that the company will report sales of $96.32 million per share. Zacks’ sales averages are a mean average based on a survey of analysts that that provide coverage for Medley Capital.
Medley Capital (NYSE:MCC) last issued its earnings results on Thursday, December 7th. The investment management company reported $0.16 EPS for the quarter, hitting the consensus estimate of $0.16. The company had revenue of $22.10 million for the quarter, compared to the consensus estimate of $23.51 million. Medley Capital had a negative net margin of 15.66% and a positive return on equity of 7.50%. The firm’s revenue for the quarter was down 18.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.23 earnings per share.
Shares of Medley Capital (MCC) opened at $5.18 on Monday. Medley Capital has a fifty-two week low of $5.09 and a fifty-two week high of $8.05. The company has a market cap of $282.18, a price-to-earnings ratio of -18.50, a PEG ratio of 1.57 and a beta of 1.22. The company has a current ratio of 11.02, a quick ratio of 11.02 and a debt-to-equity ratio of 1.06.
A number of hedge funds have recently added to or reduced their stakes in MCC. Goldman Sachs Group Inc. increased its stake in shares of Medley Capital by 44.7% during the second quarter. Goldman Sachs Group Inc. now owns 136,719 shares of the investment management company’s stock valued at $874,000 after buying an additional 42,225 shares during the period. Legal & General Group Plc boosted its position in Medley Capital by 19.8% during the third quarter. Legal & General Group Plc now owns 167,746 shares of the investment management company’s stock valued at $1,002,000 after purchasing an additional 27,708 shares in the last quarter. Royal Bank of Canada boosted its position in Medley Capital by 1,130.4% during the second quarter. Royal Bank of Canada now owns 54,013 shares of the investment management company’s stock valued at $345,000 after purchasing an additional 49,623 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new stake in Medley Capital in the third quarter worth about $311,000. Finally, Roumell Asset Management LLC acquired a new stake in Medley Capital in the third quarter worth about $2,602,000. Institutional investors and hedge funds own 29.08% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Medley Capital Corp (MCC) Expected to Post Quarterly Sales of $22.87 Million” was reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another publication, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this report can be read at https://www.americanbankingnews.com/2018/01/29/medley-capital-corp-mcc-expected-to-post-quarterly-sales-of-22-87-million.html.
Medley Capital Company Profile
Medley Capital Corporation is a non-diversified closed-end management investment company. The Company’s investment objective is to generate current income and capital appreciation by lending directly to privately-held middle market companies, primarily through directly originated transactions to help these companies expand their business, refinance and make acquisitions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medley Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medley Capital and related companies with MarketBeat.com's FREE daily email newsletter.